» Articles » PMID: 32530323

Elastases and Elastokines: Elastin Degradation and Its Significance in Health and Disease

Overview
Publisher Informa Healthcare
Date 2020 Jun 13
PMID 32530323
Citations 65
Authors
Affiliations
Soon will be listed here.
Abstract

Elastin is an important protein of the extracellular matrix of higher vertebrates, which confers elasticity and resilience to various tissues and organs including lungs, skin, large blood vessels and ligaments. Owing to its unique structure, extensive cross-linking and durability, it does not undergo significant turnover in healthy tissues and has a half-life of more than 70 years. Elastin is not only a structural protein, influencing the architecture and biomechanical properties of the extracellular matrix, but also plays a vital role in various physiological processes. Bioactive elastin peptides termed elastokines - in particular those of the GXXPG motif - occur as a result of proteolytic degradation of elastin and its non-cross-linked precursor tropoelastin and display several biological activities. For instance, they promote angiogenesis or stimulate cell adhesion, chemotaxis, proliferation, protease activation and apoptosis. Elastin-degrading enzymes such as matrix metalloproteinases, serine proteases and cysteine proteases slowly damage elastin over the lifetime of an organism. The destruction of elastin and the biological processes triggered by elastokines favor the development and progression of various pathological conditions including emphysema, chronic obstructive pulmonary disease, atherosclerosis, metabolic syndrome and cancer. This review gives an overview on types of human elastases and their action on human elastin, including the formation, structure and biological activities of elastokines and their role in common biological processes and severe pathological conditions.

Citing Articles

Alpha-1 antitrypsin deficiency and risk of sleep apnea: a nationwide cohort study.

Larsen L, Winther S, Korvel-Hanquist A, Marott S, Landt E, Homoe P Eur Arch Otorhinolaryngol. 2025; .

PMID: 40087166 DOI: 10.1007/s00405-025-09270-7.


Desmosine: The Rationale for Its Use as a Biomarker of Therapeutic Efficacy in the Treatment of Pulmonary Emphysema.

Cantor J Diagnostics (Basel). 2025; 15(5).

PMID: 40075825 PMC: 11898526. DOI: 10.3390/diagnostics15050578.


Primed Mesenchymal Stem Cells by IFN-γ and IL-1β Ameliorate Acute Respiratory Distress Syndrome through Enhancing Homing Effect and Immunomodulation.

Kong T, Seo S, Han Y, Seo W, Kim B, Kim J Biomol Ther (Seoul). 2025; 33(2):311-324.

PMID: 39973472 PMC: 11893491. DOI: 10.4062/biomolther.2025.004.


Biomarkers of Extracellular Matrix Fragments in Patients with Psoriasis.

Johansen M, Holm Nielsen S, Port H, Todberg T, Lovendorf M, Skov L Int J Mol Sci. 2025; 26(1.

PMID: 39796116 PMC: 11720200. DOI: 10.3390/ijms26010261.


Extracellular matrix in vascular homeostasis and disease.

Zhang L, Zhou J, Kong W Nat Rev Cardiol. 2025; .

PMID: 39743560 DOI: 10.1038/s41569-024-01103-0.